Epidemiological data increasingly suggest a link between repair gene polymorphisms and cancer risk, with XRCC3 implicated in various malignancies, including lymphoma, lung, esophageal, salivary gland, colorectal, cervical, breast, and stomach cancers [21–28]. This evidence concerns the gene XRCC3 and gastric cancer.